Epidemiology & Population Sciences Division

The Epidemiology and Population Sciences Division of CICMD unites investigators and trainees from across the UF campus to promote the detection, prevention, and treatment of cardiometabolic disease through research focused at the population level. Much of the focus by members in this is on observational studies of interventions or other determinants of cardiometabolic health that are conducted in the population (e.g., humans, animals) for which the intervention or determinant is directly relevant. The division is also very committed to the development of trainees with an interest in epidemiology/population science as well as those wishing to develop expertise across disciplines to advance the mission of the Center.

Areas of Focus

Major therapeutic and methodological areas of focus include:

  • Hypertension and treatment-resistant hypertension
  • Metabolic syndrome (including specific focuses on racial disparities and pediatrics)
  • Pharmacoepidemiology of antihypertensive and antidiabetic agents
  • Coronary artery disease and microvascular dysfunction in women
  • Cardiovascular effects of kidney disease
  • Optimizing use of electronic health record data in cardiometabolic research

Resources

The division seeks to support CICMD-affiliated investigators and trainees with resources for conducting population-based studies. For a comprehensive list visit the resources page.

Members and Collaborations

Jian Bian,Ph.D.

Christine Wegner, Ph.D.

Cindi Larimer, M.D.

Dominick Lemas, Ph.D.

Matthew Gurka, Ph.D.

Jaclyn Kropp, Ph.D.

Melissa Vilaro

Michael Perri, Ph.D.

Rahma  Mkuu, Ph.D.

Karla Pagan Shelnutt, Ph.D.

Steven Smith, Ph.D.

Thomas Pearson, Ph.D.

Ting-Yuan (David)Cheng , Ph.D.

Anton Stephen, Ph.D.

* The Majority of the Clinical Science Division member’s activities overlap with Epidemiology and Population Sciences.

The division also has close ties with related administrative units at UF, including the Division of Cardiovascular Medicine (COM), Department of Health Outcomes & Biomedical Informatics (COM), Department of Epidemiology PHHP, the Departments of Pharmacotherapy & Translational Research (COP), and Pharmaceutical Outcomes & Policy (COP), as well as the Center for Drug Evaluation and Safety (CoDES).